Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Aflibercept

Brand: Eylea®
NICE TA: 305
Indication: Macular oedema secondary to central retinal vein occlusion (NICE TA305)
Disease category: Eye
Commissioning responsibility: CCG
PbR excluded: Yes

Background

Aflibercept solution for injection is recommended as an option for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion only if the manufacturer provides aflibercept solution for injection with the discount agreed in the patient access scheme.

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Red

Red

Red

Red

Red